Extract
Clinical Data Reports Strong First Quarter Results.
- Achieves 39% Overall Revenue Growth
- PGxHealth(TM) Testing Revenues Grow 122% - Cogenics(TM) Revenues Grow 26 % NEWTON, Mass. -- Clinical Data, Inc. (NASDAQ:CLDA) today announced strong results for the first fiscal quarter ended June 30, 2008. Total revenue for the first quarter rose 39% to $9.2 million from $6.6 million for the same period a year ago. Revenue for Clinical Data's PGxHealth division grew at a record 114% percent to $2.0 million, including a 122% increase in sales of PGxHealth's FAMILION([R]) and PGxPredict([R]) tests. Total ...See the full content of this document
Sponsored links
